September 7, 2018 / 6:25 AM / 12 days ago

AstraZeneca gets FDA breakthrough therapy label for asthma treatment

Sept 7 (Reuters) - AstraZeneca Plc said on Friday the U.S. Food and Drug Administration had granted a breakthrough therapy label for its drug to treat a type of severe asthma, potentially speeding up its development and review.

The drug, Tezepelumab, is developed by British-listed AstraZeneca and its U.S. partner Amgen Inc. (Reporting by Nivedita Balu in Bengaluru; Editing by Sai Sachin Ravikumar)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below